Evolutionary computational methods to predict oral bioavailability QSPRs

Current Opinion in Drug Discovery and Development

Volumn 5, Issue 1, 2002, Pages 44-51

  Bains, William ^a   Gilbert, Richard ^a   Sviridenko, Lilya ^a   Gascon, Jose Miguel ^a   Scoffin, Robert ^a   Birchall, Kris ^a   Harvey, Inman ^a   Caldwell, John ^a  

^a Amedis Pharmaceuticals   (United Kingdom)

Author keywords

Genetic programming; Oral bioavailability; QSPR prediction

Indexed keywords

DRUG;

COMPUTER ANALYSIS; COMPUTER MODEL; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG METABOLISM; DRUG RESEARCH; MATHEMATICAL ANALYSIS; PHARMACOKINETICS; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REVIEW; SYSTEM ANALYSIS; TECHNIQUE;

ANIMALS; ARTIFICIAL INTELLIGENCE; BIOLOGICAL AVAILABILITY; CHEMISTRY, PHYSICAL; COMPUTATIONAL BIOLOGY; HUMANS; MODELS, CHEMICAL; PREDICTIVE VALUE OF TESTS; SOFTWARE;

EID: 0036242411     PISSN: 13676733     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (23)

1. Drug discovery in the new millennium: The pivotal role of biotechnology
2. Property-based design: Optimization of drug absorption and pharmacokinetics
3. Current methodologies used for evaluation of intestinal permeability and absorption
4. The absolute oral bioavailability of selected drugs
5. Comparative pharmacokinetics of benzodiazepines in dog and man
6. Oral drug absorption studies: The best model for man is man
7. Pharmaceutical biotechnology. Genetics, genomics and drug discovery
8. Predicting the impact of physiological and biochemical processes on oral drug bioavailability
9. Pharmacophore and three-dimensional quantitative structure activity relationship methods for modelling cytochrome p450 active sites
10. Mapping the binding site of the small intestinal peptide carrier (PepT1) using comparative molecular field analysis
11. Minimal molecular determinants of substrates for recognition by the intestinal peptide transporter
12. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells
13. MDCK (Madin-Darby canine kidney) cells: A tool for membrane permeability screening
14. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings
15. Application of neural networks to candidate selection
16. QSAR model for drug human oral bioavailability
17. Analysis of a large structure/biological activity data set using recursive partitioning
18. Predicting human oral bioavailability of a compound: Development of a novel quantitative structure-bioavailability relationship
19. Genetic programming for combining neural networks for drug discovery